PHRRF (PharmaTher Holdings) Moat Score: 2/10 (As of Jul. 02, 2026)


What is PharmaTher Holdings Moat Score?

PharmaTher Holdings PHRRF -5.41% Moat Score is 2 as of Jul. 02, 2026. The stock has 2 warning signs investors should review. Among 1,400 Biotechnology companies, PharmaTher Holdings ranks better than 58.07% on this metric.

PharmaTher Holdings has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

PharmaTher Holdings has No Moat: PharmaTher Holdings Ltd lacks significant intellectual property or market leadership. The company does not have strong brand strength, regulatory barriers, or cost advantages, resulting in a weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes PharmaTher Holdings might have No Moat - Very weak/transient advantages.

PharmaTher Holdings  (OTCPK:PHRRF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

PharmaTher Holdings Moat Score Related Terms

PHRRF vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, PharmaTher Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaTher Holdings Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
PharmaTher Holdings (PHRRF) has a Moat Score of 2 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, PharmaTher Holdings ranks #587 out of 1400 companies in the Biotechnology industry, placing it in the top 41.9%.
Is PharmaTher Holdings' Moat Score too high?
PharmaTher Holdings' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. PharmaTher Holdings' value of 2 is 0% at this industry median. Based on the distribution chart, PharmaTher Holdings ranks #587 out of 1400 companies in the Biotechnology industry, which is above the industry midpoint.
How does PharmaTher Holdings' Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PharmaTher Holdings ranks #587 out of 1400 companies for Moat Score. This puts PharmaTher Holdings in the upper half of its industry. The industry median Moat Score is 2.00. PharmaTher Holdings' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,400 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaTher Holdings's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaTher Holdings's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current Moat Score is 2 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.